SCOTTSDALE, Ariz.—The benefits of treating neuropathic pain early to prevent the chronic phase of complex regional pain syndrome (CRPS) type II were shared with a case study presented at the American Academy of Pain Medicine 2022 Annual Meeting.
CRPS is categorized into two types: type I, of which there is no nerve injury, and type II, of which there is a confirmed nerve injury.
“The nature of pain in type I is thought to be predominantly nociceptive, whereas type II is believed to be